NCT07108855View on ClinicalTrials.gov

Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

August 1, 2027

Conditions
Esophageal CarcinomaGastric Carcinoma
Interventions
DRUG

Indocyanine Green (IC-Green)

Systemic administration of indocyanine green during the endoscopic procedure.

DIAGNOSTIC_TEST

Fluorescence guided identification using indocyanine green

Near-infrared quantified fluorescence molecular endoscopy (qFME) will be used during the endoscopic procedure.

Trial Locations (1)

9713GZ

RECRUITING

University Medical Centre Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT07108855 - Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection | Biotech Hunter | Biotech Hunter